Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants-Reference-Cited by-同舟云学术

Big Data Analyses for Continuous Evaluation of Pharmacotherapy: A Proof of Principle with Doxapram in Preterm Infants

Published:2018-02-09 Issue:38 Volume:23 Page:5919-5927
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Flint Robert B.¹,Weteringen Willem van²,Völler Swantje³,Poppe Jarinda A.⁴,Koch Birgit C.P.⁵,Groot Ronald de⁶,Tibboel Dick⁷,Knibbe Catherijne A.J.³,Reiss Irwin K.M.⁴,Simons Sinno H.P.⁴,DINO Research group Bentham Science Publisher⁸

Affiliation:

1. Erasmus Medical Center - Sophia Children’s Hospital, Department of Pediatrics, Division of Neonatology, Wijtemaweg 80, 3015 CN Rotterdam,, Netherlands

2. Department of Pediatric Surgery, Erasmus University Medical Center - Sophia Children’s Hospital, Rotterdam, Netherlands

3. Division of Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, Netherlands

4. Department of Pediatrics, Division of Neonatology, Erasmus University Medical Center - Sophia Children’s Hospital, Rotterdam, Netherlands

5. Department of Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands

6. Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands

7. Intensive Care and Department of Pediatric Surgery, Department of Pediatrics, Erasmus University Medical Center - Sophia Children’s Hospital, Rotterdam, Netherlands

8. Netherlands

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines;Journal of Controlled Release;2021-02

2. A Deep Convolutional Neural Network to Improve the Prediction of Protein Secondary Structure;Current Bioinformatics;2020-12-15

3. The bioavailability and maturing clearance of doxapram in preterm infants;Pediatric Research;2020-07-22

4. Precision Dosing of Doxapram in Preterm Infants Using Continuous Pharmacodynamic Data and Model-Based Pharmacokinetics: An Illustrative Case Series;Frontiers in Pharmacology;2020-05-12

5. “How can a drug to treat claudication in adults save preterm newborns?”;European Journal of Pediatrics;2020-03-16